Development of Clinical Use of Biological Agents on Juvenile Idiopathic Arthritis / 实用儿科临床杂志

ABSTRACT

Juvenile idiopathic arthritis(JIA)is the most common rheumatology disease in childhood period with poor prognosis.The biological agents are newly developed drugs with features of clear therapeutic targets and fast effects.But its use in JIA is still limited,so this article focuses on the clinical use experience,timming and sideffects of the biological agents on JIA.